| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 54 | 1.868 | 1.439 | 7.723 | 7.601 |
| Total Income - EUR | - | - | - | - | - | 54 | 1.868 | 1.439 | 7.723 | 7.601 |
| Total Expenses - EUR | - | - | - | - | - | 0 | 19 | 81 | 166 | 4.075 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 54 | 1.849 | 1.358 | 7.557 | 3.526 |
| Net Profit/Loss - EUR | - | - | - | - | - | 52 | 1.800 | 1.317 | 6.468 | 2.977 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cicămed Neuro 2020 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 963 |
| Current Assets | - | - | - | - | - | 95 | 1.919 | 1.379 | 6.959 | 3.811 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 55 | 55 | 4.583 | 3 |
| Cash | - | - | - | - | - | 95 | 1.865 | 1.324 | 2.376 | 3.808 |
| Shareholders Funds | - | - | - | - | - | 93 | 1.891 | 1.366 | 6.517 | 4.069 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2 | 28 | 13 | 442 | 705 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cicămed Neuro 2020 S.r.l.